June 2026
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 18.43 billion by 2035 increasing from USD 8.44 billion in 2025, with a CAGR of 8.12%.
April 2026
The global multiple sclerosis drugs market size is estimated to hit around USD 49.13 billion by 2035, increasing from USD 22.96 billion in 2025, with a CAGR of 7.90%.
June 2026
The global atherosclerosis drugs market size is projected to hit around USD 25.07 billion by 2035, increasing from USD 17.60 billion in 2025, with a CAGR of 3.60%.
June 2026
The U.S. over the counter (OTC) drugs market size is expected to increase from USD 24.81 billion in 2025 and is predicted to hit USD 46.67 billion by 2035, with a CAGR of 6.52%.
May 2026
The global multiple sclerosis therapeutics market size was evaluated at USD 34.80 billion in 2025 and is predicted to hit around USD 66.80 billion by 2035, growing at a CAGR of 6.90%.
May 2026
The U.S. pain management drugs market size was estimated at USD 32.79 billion in 2025 and is projected to hit around USD 46.50 billion by 2035, at a CAGR of 3.56%.
May 2026
The global multiple sclerosis diagnostics market size was evaluated at USD 5.70 billion in 2025 and is predicted to hit around USD 12.88 billion by 2035, growing at a CAGR of 8.80%.
February 2026
The U.S. generic drugs market size was exhibited at USD 146.04 billion in 2025 and is projected to hit around USD 243.70 billion by 2035 with a CAGR of 5.25%.
June 2025
The U.S. asthma drugs market size was evaluated at USD 8.79 billion in 2024 and is predicted to surge to around USD 14.36 billion by 2034 with a CAGR of 5.03%.
June 2026
The U.S. compounding pharmacies market size is valued at USD 6.45 billion in 2025 and is expected to hit around USD 11.52 billion by 2035, growing at a CAGR of 5.97%.
June 2026
The global epigenetic drugs market size is anticipated at USD 16.22 billion in 2025 and is predicted to hit around USD 92.57 billion by 2035, growing at a CAGR of 19.03%.
June 2026
The U.S. nutraceuticals market size was estimated at USD 179.83 billion in 2025 and is projected to surpass around USD 282.04 billion by 2035 with a CAGR of 4.6%.
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
The global rheumatoid arthritis drugs market size was valued at USD 64.35 billion in 2025 and is expected to hit around USD 76.83 billion by 2035, growing at a CAGR of 1.79% from 2026 to 2035.
June 2026
The global U.S. biofuels market size was estimated at USD 50.07 billion in 2025 and is projected to hit around USD 96.51 billion by 2035, with a CAGR of 5.17%.
June 2026
The U.S. intra-abdominal pressure measurement devices market size was estimated at USD 71.26 billion in 2025 and is expected to hit around USD 158.82 billion by 2035, growing at a CAGR of 8.34%.
June 2026
The U.S. patient engagement solutions market size surpass USD 7.40 billion in 2025 and is projected to cross around USD 27.83 billion by 2035 with a CAGR of 14.16%.
June 2026
The global PD-1 inhibitor drugs market size was estimated at USD 48.69 billion in 2025 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
June 2026
The global orphan drugs market size was surpass to USD 216.55 billion in 2025 and is projected to reach around USD 676.59 billion by 2035 with a CAGR of 12.07%.
June 2026
The U.S. vehicle-to-grid technology market size is evaluated at USD 1.85 billion in 2025 and is projected to surpass around USD 25.43 billion by 2035 with a solid CAGR of 33.80%.
June 2026
The U.S. DNA nanotechnology market size is accounted to hit around USD 18.03 billion by 2035 increasing from USD 2.01 billion in 2025, with a CAGR of 24.53%.
June 2026
The U.S. concierge medicine market size is valued at USD 6.55 billion in 2025 and is projected to be worth around USD 12.75 billion by 2035 with CAGR of 6.88%.
June 2026
The global dermatology drugs market size was calculated at USD 23.86 billion in 2025 and is projected to hit around USD 69 billion by 2035 with a CAGR of 11.2% .
June 2026
The U.S. revenue cycle management market size was valued at USD 65.43 billion in 2025 and is predicted to hit around USD 191.67 billion by 2035, at a CAGR of 11.50%.
June 2026
The U.S. liquid biopsy market size is projected to hit around USD 6.62 billion by 2035, rising from USD 1.85 billion in 2025, growing at a CAGR of 13.55%.
June 2026
The global insulin drugs and delivery devices market size is evaluated at USD 25.53 billion in 2025 and is predicted to hit around USD 52.72 billion by 2035, growing at a CAGR of 7.52%.
June 2026
The U.S. ambulatory surgical center market size reached USD 43.43 billion in 2025 and is projected to hit around USD 66.63 billion by 2035, with a CAGR of 4.61%.
June 2026
The US cardiovascular drugs market size was evaluated at USD 28.42 billion in 2025 and is predicted to hit around USD 37.03 billion by 2035, growing at a CAGR of 2.68%.
June 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
June 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com